Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PM vs MRNA✓SelectedUSD · MRNAPM vs MRNA performance historyLatest closeAs of-0.85%11/18
Stock and ETF performance explorer

PM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+241.4%
MRNA return
+794.5%
Excess return
-553.1%
Maximum drawdown
-31.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.8%-4.8%+4.0%-0.8%
7D-1.8%-20.9%+19.0%-1.8%
30D-4.1%-13.3%+9.1%-4.1%
3M+3.6%+212.6%-209.0%+2.6%
6M+2.3%+309.0%-306.7%+1.2%
YTD+23.3%+567.3%-544.0%+21.6%
1Y+28.0%+689.7%-661.6%+26.1%
3Y+137.0%+157.4%-20.4%+135.8%
5Y+164.9%-21.7%+186.7%+164.4%
All+241.4%+794.5%-553.1%+220.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling